2. First things first
Depression is a medical condition & not any fault of the
individual concerned.
Assessment & evaluation is mandatory-Severity, etiology
& risk-factors.
Treatment plan comprises of medication, psychological &
social support.
5. Mode of action
All antidepressants function by increasing availability
of monoamines (5-HT, NA or DA) by one of the
following methods:
Presynaptic inhibition of reuptake of 5-HT, NA or DA.
Antagonist activity at presynaptic inhibitory 5HT or NA
receptors which enhances neurotransmitter release.
Inhibition of Monoaminase oxidase, reducing NT
breakdown.
Increasing availability of NT precursors.
Initial resolution of depressive symptoms takes minimum
of 2-4 weeks.
14. Side-effects
Dry mouth,
Caution:
Blurred vision,
Arrhythmias & ECG
Sedation,
changes. Monitor
Orthostatic hypotension,
Cardiac function, LFTs,
Constipation,
UCEs.
urinary incontinence.
Disorientation or
Should be used
confusion
cautiously in elderly.
15. SNRIs (Serotonin-norepinephrine reuptake
inhibitors )
Mechanism: Similar to SSRI, Inhibit 5HT & NA (high doses DA)
Indications: GAD, Depression.
Venlafaxine (Efexor)
Duloxetine (Oxcym DR, Hapibar, Lyta)
Levomilnacipran (Fetzima)
Tramadol (Tramal, Ultram)
Sibutramine (Meridia, Reductil)
Side-effects: Similar to SSRIs & may cause HTN.
16. MAOIs (Monoamine oxidase inhibitors)
Irreversible inhibition of MAO-A
(acts on NA, DA, 5HT & Tyramine) &
MAO-B (acts on DA, Tyramine,
Phenylethylamine, benzylamine)
leading to accumulation of
monoamines in Synaptic Cleft.
RIMAs: Reversible inhibition
of MAO-A.